Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

Ítems similars

• Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
  per: Sestini, Stefano, et al.
  Publicat: (2015)
• MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
  per: Mensah, Mavis, et al.
  Publicat: (2017)
• Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
  per: Sozzi, Gabriella, et al.
  Publicat: (2014)
• MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature
  per: Fortunato, Orazio, et al.
  Publicat: (2016)
• Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations()
  per: Hu, Jiangting, et al.
  Publicat: (2015)